Regeneron Pharmaceuticals, Inc. (REGN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 80.74B |
| Enterprise Value | 80.33B |
| P/E Ratio | 14.34 |
| PEG Ratio | 7.78 |
| Price/Sales Ratio | 4.21 |
| Price/Book Ratio | 2.02 |
| Enterprise/Revenue | 4.19 |
| Enterprise/EBITDA | 10.89 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.3 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.11 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 14.34B |
| Revenue/Share | 143.46 |
| Gross Profit | 12.24B |
| EBITDA | 5.82B |
| Net Income | 4.5B |
| Diluted EPS | 41.48 |
Balance Sheet
| Total Cash | 8.75B |
| Total Cash/Share | 84.17 |
| Total Debt | 2.71B |
| Total Debt/Equity | 0.09 |
| Current Ratio | 3.57 |
| Book Value Per Share | 302.15 |
Price History
| 52-Week Change | 19.15 |
| 52-Week High | 821.11 |
| 52-Week Low | 507.61 |
| Moving Average 50 Days | 680.04 |
| Moving Average 200 Days | 697.07 |
Statistics
| Average Volume | 929,211 |
| Shares Outstanding | 103.02M |
| % Held by Institutions | 84.4 |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.64 |
| Trailing Annual Dividend Yield | 0.6 |
| Payout Ratio | 0.08 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
